CSIMarket
 


Athersys Inc  (ATHX)
Other Ticker:  
 

Athersys Inc's Quick Ratio

ATHX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 0.03 a new company low.

Within Major Pharmaceutical Preparations industry 474 other companies have achieved higher Quick Ratio than Athersys Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 3742 to 4097.

Explain Quick Ratio?
How much Cash & cash equivalents ATHX´s has?
What are ATHX´s Current Liabilities?


ATHX Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change -0.27 % 28.52 % 28.15 % 28.74 % 39.92 %
Y / Y Cash & cash equivalent Change -92.6 % -86.52 % -85.68 % -75.84 % -72.25 %
Quick Ratio MRQ 0.03 0.04 0.08 0.24 0.36
ATHX's Total Ranking # 4097 # 3742 # 3381 # 3362 # 3029
Seq. Current Liabilities Change -9.54 % 7.6 % 3.22 % -0.74 % 16.58 %
Seq. Cash & cash equivalent Change -43.43 % -42.23 % -65.47 % -34.42 % 3.02 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 475
Healthcare Sector # 968
Overall Market # 4097


Quick Ratio Statistics
High Average Low
10.55 3.37 0.03
(Mar 31 2014)   (Sep 30 2023)




Financial Statements
Athersys Inc's Current Liabilities $ 39 Millions Visit ATHX's Balance sheet
Athersys Inc's Cash & cash equivalent $ 1 Millions Visit ATHX's Balance sheet
Source of ATHX's Sales Visit ATHX's Sales by Geography


Cumulative Athersys Inc's Quick Ratio

ATHX's Quick Ratio for the trailling 12 Months

ATHX Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -0.27 % 28.52 % 28.15 % 28.74 % 39.92 %
Y / Y Cash & cash equivalent TTM Growth -92.6 % -86.52 % -85.68 % -75.84 % -72.25 %
Quick Ratio TTM 0.09 0.17 0.26 0.41 0.65
Total Ranking TTM # 3552 # 3968 # 4127 # 4036 # 1876
Seq. Current Liabilities TTM Growth -9.54 % 7.6 % 3.22 % -0.74 % 16.58 %
Seq. Cash & cash equivalent TTM Growth -43.43 % -42.23 % -65.47 % -34.42 % 3.02 %


On the trailing twelve months basis In spite of the year on year decrease in ATHX's Current Liabilities to $38.62 millions, cumulative Quick Ratio to 0.09 below the ATHX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 474 other companies have achieved higher Quick Ratio than Athersys Inc. While Quick Ratio overall ranking has improved so far to 3552, from total ranking during the twelve months ending second quarter 2023 at 3968.

Explain Quick Ratio?
How much Cash & cash equivalents ATHX´s has?
What are ATHX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 475
Healthcare Sector # 977
Within the Market # 3552


trailing twelve months Quick Ratio Statistics
High Average Low
7.81 2.82 0.09
(Dec. 30, 2014)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Cytodyn inc   0.07 $ 8.572  Millions$ 129.053  Millions
Kintara Therapeutics Inc   0.06 $ 0.216  Millions$ 3.336  Millions
Nexien Biopharma Inc   0.06 $ 0.018  Millions$ 0.313  Millions
Alzamend Neuro Inc   0.05 $ 0.200  Millions$ 3.666  Millions
Renovaro Inc   0.05 $ 0.523  Millions$ 10.096  Millions
Inmed Pharmaceuticals Inc   0.04 $ 0.043  Millions$ 1.046  Millions
Provectus Biopharmaceuticals Inc   0.04 $ 0.367  Millions$ 9.172  Millions
Actavia Life Sciences Inc   0.04 $ 0.075  Millions$ 2.052  Millions
Bioxytran Inc   0.03 $ 0.080  Millions$ 2.333  Millions
Avenue Therapeutics Inc   0.03 $ 0.161  Millions$ 5.024  Millions
Athersys Inc  0.03 $ 1.020  Millions$ 38.624  Millions
Emmaus Life Sciences Inc   0.02 $ 1.505  Millions$ 60.917  Millions
Regen Biopharma Inc  0.02 $ 0.121  Millions$ 5.308  Millions
Tenx Keane Acquisition  0.02 $ 0.027  Millions$ 1.164  Millions
Hst Global Inc   0.02 $ 0.002  Millions$ 0.093  Millions
One World Products Inc   0.02 $ 0.095  Millions$ 4.513  Millions
Vaccinex Inc   0.02 $ 0.127  Millions$ 6.195  Millions
Baudax Bio Inc   0.02 $ 0.363  Millions$ 19.051  Millions
Oncotelic Therapeutics Inc   0.02 $ 0.268  Millions$ 17.111  Millions
Avenir Wellness Solutions Inc   0.01 $ 0.189  Millions$ 12.789  Millions
Acer Therapeutics Inc   0.01 $ 0.595  Millions$ 61.670  Millions
Kaya Holdings Inc  0.01 $ 0.060  Millions$ 7.771  Millions
Axim Biotechnologies Inc   0.01 $ 0.032  Millions$ 4.278  Millions

Date modified: 2023-11-17T20:42:12+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com